SCHEMBL2733345

SCHEMBL2733345

CC(C)(C)c1ccc(C(=O)OCC2CC2)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CARM1 Q86X55 1/20 0.45
PRMT6 Q96LA8 1/20 0.45
DRD2 P14416 1/20 0.45
DRD4 P21917 1/20 0.45
CA1 P00915 1/20 0.44
CA2 P00918 1/20 0.44
BCHE P06276 2/20 0.44
TDP1 Q9NUW8 2/20 0.44
MAPT P10636 2/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
HDAC1 Q13547 1/20 0.43
JMJD6 Q6NYC1 1/20 0.43
ALDH1A1 P00352 2/20 0.43
LMNA P02545 1/20 0.43
ALOX15 P16050 1/20 0.43
APEX1 P27695 1/20 0.43
MAPK1 P28482 1/20 0.43
RECQL P46063 1/20 0.43
HSD17B10 Q99714 1/20 0.43
RAB9A P51151 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13498613 1.00 CARM1 (0.45) CARM1PRMT6DRD2DRD4CA1
SCHEMBL14398313 0.90 MEN1 (0.49) CARM1PRMT6DRD2DRD4BCHE
SCHEMBL13498615 0.84 CES2 (0.47) CARM1PRMT6DRD2DRD4MAPT
SCHEMBL23928027 0.81 CARM1 (0.48) CARM1PRMT6DRD2DRD4CA1
SCHEMBL11843612 0.81 RAB9A (0.50) CARM1PRMT6DRD2DRD4CA1
SCHEMBL14665431 0.81 CARM1 (0.48) CARM1PRMT6DRD2DRD4CA1
SCHEMBL13498612 0.81 RAB9A (0.50) CARM1PRMT6DRD2DRD4CA1
SCHEMBL2734307 0.81 CA1 (0.43) CA1CA2BCHETDP1MAPT
SCHEMBL3240666 0.81 MAPT (0.45) CA1CA2TDP1MAPTL3MBTL1
SCHEMBL13498614 0.80 POLB (0.55) CARM1PRMT6DRD2DRD4CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8088566-B2 Photoresists; using compound containing an orgaooxygen or organosulfur compound FUJIFILM CORPORATION (JP) 2012-01-03 US disclosed
US-8088566-B2 Photoresists; using compound containing an orgaooxygen or organosulfur compound FUJIFILM CORPORATION (JP) 2012-01-03 US disclosed
US-20080241742-A1 SURFACE-TREATING AGENT FOR PATTERN FORMATION AND PATTERN-FORMING METHOD USING THE SURFACE-TREATING AGENT FUJIFILM CORPORATION (JP) 2008-10-02 US disclosed
US-20080241742-A1 SURFACE-TREATING AGENT FOR PATTERN FORMATION AND PATTERN-FORMING METHOD USING THE SURFACE-TREATING AGENT FUJIFILM CORPORATION (JP) 2008-10-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080241742-A1 SURFACE-TREATING AGENT FOR PATTERN FORMATION AND PATTERN-FORMING METHOD USING THE SURFACE-TREATING AGENT KRT18, FSCN1, SLC11A2 CARM1 1250/4885PRMT6 461/4885DRD2 2934/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.